U.S. Online Retail and Ecommerce Stock News

VisionWave Holdings (VWAV) is in focus after using Eurosatory 2026 in Paris to publicly show its VARAN autonomous unmanned ground vehicle, STRATUM AI management platform, and SDNN AI architecture to the global defense community. See our latest analysis for VisionWave Holdings. Alongside the Eurosatory reveal and new data center joint venture term sheet, VisionWave Holdings has seen short term momentum pick up, with a 7 day share price return of 16.06% and a 30 day return of 9.47%. However,...

How Donnelley Financial Solutions stock is reacting to its new AI iXBRL launch Donnelley Financial Solutions (DFIN) has drawn fresh attention after unveiling an AI-powered iXBRL tagging capability for SEC filings, initially focused on Tailored Shareholder Reports and N-CSR submissions within its Arc Suite platform. The product combines large language models with SEC taxonomy expertise and human review, aiming to cut manual tagging work while maintaining strict control over regulatory accuracy...

In recent trading, oil prices extended their decline as Brent crude slipped below US$80 per barrel and WTI approached US$75, driven in part by the Iran peace deal and weaker revenue expectations across the energy complex. This drop in crude is pressuring producers to scale back drilling capital expenditures, which in turn weighs on infrastructure and oilfield services providers such as Calumet, whose business is closely linked to upstream activity and broader energy demand. We will now...

Equity Residential (EQR) has come back into focus after recent trading left the stock around $64.63, with returns that have moved in different directions over the past month and the past 3 months. See our latest analysis for Equity Residential. Short term momentum for Equity Residential has softened, with the 1 day share price return down 2.67% and the 7 day share price return down 4.41%. The 90 day share price return of 8.97% contrasts with a 1 year total shareholder return that is down...

Recent defense milestones underscore Virtuix's expanding presence in AI-enabled military training and simulation.

The Fed’s latest meeting left rates steady at 3.5% to 3.75%, but a hint of a possible hike later this year, firmer inflation at 4.2%, and a push toward new data sources have quickly reshaped how investors think about risk and opportunity. For technology and data analytics stocks, the focus on real time information and alternative datasets could matter as much as the rate path itself. This article highlights 3 stocks from a US Technology and Data Analytics Providers screener that appear...

Ryerson Holding (RYZ) has drawn fresh attention after recent trading, with the stock moving from short term pressure to gains over the past month and the past 3 months, prompting a closer look at fundamentals. See our latest analysis for Ryerson Holding. At a share price of $28.04, Ryerson Holding has pulled back slightly in the past week after strong recent momentum, with a 30 day share price return of 13.89% and a 1 year total shareholder return of 40.55% contrasting with a weaker 3 year...

Bristol Myers Squibb (NYSE:BMY) reported positive late-stage clinical trial results for two multiple myeloma candidates. The company announced successful Phase III data for mezigdomide in combination with Kyprolis and dexamethasone. Early data for its CAR T-cell therapy arlocabtagene autoleucel showed a strong response rate with a manageable safety profile. The results were presented at the European Hematology Association Congress 2026. Bristol Myers Squibb is a global biopharmaceutical...

Earlier this month, Dolby Laboratories and NBCUniversal announced that Peacock streamed Telemundo’s live Spanish-language coverage of all 104 FIFA World Cup 2026 matches in Dolby Vision and Dolby Atmos using Dolby AC-4, marking the first commercial use of this codec by a video streamer. Beyond enhancing picture and sound, this rollout positions Dolby’s AC-4 and immersive formats at the core of a high-profile global sports event, reinforcing its role as a go-to technology partner for...

How Ladder Capital Stock Has Been Performing Recently Ladder Capital (LADR) has drawn investor attention after a mixed run in its share price, with the stock down over the year to date but showing gains over the past 3 months and year. This performance sits against reported revenue of $216.26 million and net income of $55.012 million, figures that help frame how the market is currently pricing this US$1.31b real estate investment trust. See our latest analysis for Ladder Capital. The latest...

Coach, part of Tapestry (NYSE:TPR), has launched &Coach, a digital luxury content platform co-created with Gen Z. The platform focuses on social first storytelling and participatory campaigns, with younger creators embedded in the process. &Coach is intended to reshape how the Coach brand builds community and relevance with younger luxury consumers. Tapestry, trading at $145.87, sits behind Coach as its flagship brand and is leaning into a content driven approach to connect with younger...

Tariffs, shifting trade rules, and pressure on global supply chains are reshaping how investors think about US manufacturing stocks. Instead of relying on smooth cross-border trade, markets are reassessing companies that produce more at home and can better control their costs and inputs. This article looks at three US Domestic Manufacturing screener stocks that are directly exposed to these trade headlines and may react in different ways as policies evolve. Each stock is assessed on its...

With Kevin Warsh preparing for his first post-meeting press conference and the Federal Reserve keeping rates at 3.6% while inflation sits at 4.2%, many investors are rethinking how much risk they want to carry. Large-cap defensive stocks, often backed by steady dividends and stronger balance sheets, can look relatively appealing when rate cuts seem less likely and market swings pick up. This article highlights 3 stocks from our Large-Cap Defensive Stocks screener that appear positively...

With the Federal Reserve hinting at possible rate hikes in 2026 and inflation holding at 4.2%, value stocks are back in focus for investors who care about price tags as much as potential. Higher-for-longer rates can reward companies with resilient balance sheets and sensible valuations, while putting pressure on those priced for perfection. This article highlights three value stocks from our screener that are closely exposed to the latest Fed and inflation news. It explains why some investors...

Insider Selling and Valuation Concerns Put Impinj Stock in Focus Impinj (PI) shares fell 5.0% on June 16, 2026, after renewed attention on valuation, with the stock trading 5.5% above its estimated intrinsic value and recent insider selling totaling US$49.4 million. See our latest analysis for Impinj. The latest drop in Impinj's share price fits into a mixed picture, with a 23.29% 90 day share price return contrasting with a year to date share price decline of 31.35%. At the same time, the 5...

If you are wondering whether Corcept Therapeutics stock is still attractively priced after a strong run, the key question now is how its current share price compares with a reasonable view of fair value. The stock last closed at US$81.75, with returns of 4.6% over the past week, 48.3% over the past month, 114.0% year to date, 14.8% over the past year, 264.0% over three years, and 267.3% over five years. These figures naturally raise questions about how much of the story might already be...

Wondering if Yum China Holdings stock still offers value at current levels, or if the recent moves have already priced in the story? This article walks through what the numbers are saying right now. The share price closed at US$43.28, with returns that declined 1.2% over the past week, 4.8% over the past month, and 10.2% year to date. Over longer periods, the share price has risen 3.5% over the past year and declined 20.9% over three years and 30.0% over five years. These shifts can change...

Earlier in June 2026, GH Research PLC reported full Phase 2a results for its inhaled Mebufotenin (GH001) in postpartum depression, showing rapid remission in all 10 patients, improved maternal functioning, and a favorable safety profile, with findings published in The Journal of Clinical Psychiatry and highlighted at the upcoming CINP 2026 congress. An additional practical insight from the trial was that drug levels in breast milk supported only a brief interruption of breastfeeding around...

John Wiley & Sons (WLY) closed FY 2026 with fourth quarter revenue of US$447.9 million and basic EPS of US$2.65, supported by trailing twelve month EPS of US$4.22 on revenue of US$1.68 billion. Over recent periods, the company has seen quarterly revenue move from US$404.6 million in FY 2025 Q3 to US$442.6 million in FY 2025 Q4 and then to US$447.9 million in FY 2026 Q4. Basic EPS shifted from a loss of US$0.43 in FY 2025 Q3 to US$1.27 in FY 2025 Q4 and US$2.65 in FY 2026 Q4, alongside...

PulteGroup (PHM) has drawn investor attention after recent share price moves, with the stock up 13.3% over the past month and 6.6% in the past 3 months, outpacing its shorter term returns. See our latest analysis for PulteGroup. Looking beyond the recent move, PulteGroup’s 1-year total shareholder return of 27.38% and 3-year total shareholder return of 70.49% indicate that the latest share price strength around $124.76 continues a broader period of positive momentum. If you want to see what...

Prosperity Bancshares (PB) stock has drawn attention after recent trading performance, with the shares closing at $71.60. Investors are assessing how the bank's current valuation compares with its profitability and growth profile. See our latest analysis for Prosperity Bancshares. The recent 1 month share price return of 7.67% and 3 month share price return of 11.72% suggest improving momentum for Prosperity Bancshares, while the 1 year total shareholder return of 10.19% points to steadier...

Earlier in 2026, CorMedix Inc. reported strong Q1 results driven by DefenCath and raised its full-year 2026 guidance while outlining progress on late-stage programs such as REZZAYO. Management also emphasized continued business momentum even as the company prepares for the expiration of temporary TDAPA reimbursement, highlighting execution in a changing reimbursement backdrop. Next, we will examine how CorMedix's raised 2026 guidance and DefenCath’s contribution shape the company’s broader...

While Transocean stock trades around US$5.59, you might be wondering whether that price reflects a bargain, a fair deal, or hidden risk in plain sight. Recent returns show a mixed picture, with the share price declining 4.8% over the past week and 20.6% over the past month, yet still up 31.8% year to date and 74.1% over the past year. These moves sit against a backdrop of ongoing interest in offshore drilling and changing sentiment around energy services stocks, which can quickly reshape how...

Ardelyx (ARDX) is back in focus after recent trading, with the stock closing at $5.67 and showing mixed short term performance, including a decline over the past month and a gain over the past 3 months. See our latest analysis for Ardelyx. Looking beyond the latest move, Ardelyx’s share price return is down over the past month but slightly up over the past quarter, while its 1 year total shareholder return is strongly positive. This suggests earlier optimism is being reassessed rather than...